| Search Bills by: | Bill Quick Search: | Bill Tracking: |
|
All Bills (House | Senate) All Resolutions Subject Short Title Sponsor Date Introduced Code Affected All Same As Pending In Committee Reported From Committee Passed One Chamber Fiscal Notes Completed Legislation Actions by Governor View Public Comments |
| Legislative Session: 2017(RS) | |
| LAST ACTION: | H To House Prevention and Treatment of Substance Abuse 02/08/17 |
| SUMMARY: | Authorizing the medical use of cannabis based pharmaceutical products |
| LEAD SPONSOR: |
Bates |
| SPONSORS: | Ellington, Fleischauer |
|
BILL TEXT:
Bill Definitions |
Introduced Version -
html
| pdf
|
| CODE AFFECTED: |
§16 - 51 - 1
(New Code)
§16 - 51 - 2 (New Code) §16 - 51 - 3 (New Code) §16 - 51 - 4 (New Code) §60A—2—204 (Amended Code) |
| SUBJECT(S): |
Health |
| Description | Date | Journal Page | |
|---|---|---|---|
| H | To House Prevention and Treatment of Substance Abuse | 02/08/17 | 99 |
| H | Introduced in House | 02/08/17 | 99 |
| H | To Prevention and Treatment of Substance Abuse then Health and Human Resources then Judiciary | 02/08/17 | 99 |
| H | Filed for introduction | 02/08/17 | 99 |
